WINDLAS BIOTECH
|
The Current P/E Ratio of WINDLAS BIOTECH is 30.47.
Share Price | ₹941.3 | Sep 23,2025 |
Market Cap | ₹1,986.0 Cr | |
Earnings-TTM | ₹65.2 Cr | TTM-Consolidated Results |
Price/Earnings | 30.47x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WINDLAS BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,986.0 Cr] as on Sep 23,2025
(/) Earnings [ ₹65.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 30.47x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay 30.47 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WINDLAS BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WINDLAS BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of WINDLAS BIOTECH
PE Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 15.43x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 12.02x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2025 at 35.78x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WINDLAS BIOTECH | 65.18 | 30.47 | 1,986.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.59 | 391,368.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 69.66 | 160,631.0 |
CIPLA LTD | 5,406.81 | 22.83 | 123,419.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.76 | 123,641.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 19.06 | 109,176.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.51 | 105,776.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.68 | 105,187.0 |
LUPIN LTD | 3,722.18 | 24.61 | 91,611.2 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.86 | 64,474.8 |
ABBOTT INDIA LTD | 1,452.29 | 44.26 | 64,282.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WINDLAS BIOTECH 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.86x |
Max industry PE | 69.66x |
Median industry PE | 30.47x |
Average industry PE | 37.03x |
You may also like the below Video Courses